Novo Nordisk (spons. ADRs) Aktie
82,40
EUR
-17,00
EUR
-17,10
%
85,04
USD
+0,06
USD
+0,07
%
Novo Nordisk (spons. ADRs) Aktie Analyse
30.05.12 | Novo Nordisk (spons. ADRs) underperform | Cheuvreux SA | |
22.03.12 | Novo Nordisk (spons. ADRs) sell | Deutsche Bank AG | |
22.03.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
21.02.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
30.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
13.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
09.11.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
28.10.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
Werbung
|
|||
28.09.05 | Novo Nordisk (spons. ADRs) Underweight | JP Morgan |